Portfolio companies collaborate against COVID-19
Mercia Asset Management PLC today announces that two of its direct portfolio companies, The Native Antigen Company Limited (“NAC”) and Oxford Genetics Limited (trading as “OXGENE”) have formed a new strategic partnership to scale up COVID-19 antigen production. Current COVID-19 tests use the polymerase chain reaction that detects the virus’s genome. Although an important first step, these